Fiche centre
GSK Investigational Site
Tokyo — Japan
Essais liés2clinical trials
VilleTokyolocalisation
PaysJapanlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06411249
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Belimumab (GSK1550188) | Lupus | Phase 4 | NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING |
| GSK1550188 IV | Lupus | Phase 1 | NCT01516450 | Japanese phase1 Study of Belimumab (IV vs SC) | COMPLETED |